Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kurnik

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|April 18, 2026
Does mifamurtide affect the elimination of high-dose methotrexate in children with osteosarcoma?Maayan Antebi, Laila Nassar, Daniel Kurnik, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activityDaniel Kurnik, Alastair J J Wood, Grant R Wilkinson
British Journal of Clinical Pharmacology|July 27, 2010
Warfarin and vitamin K intake in the era of pharmacogeneticsYael Lurie, Ronen Loebstein, Daniel Kurnik, et al.
The Israel Medical Association Journal : IMAJ|July 12, 2021
Polypharmacy among pediatric cancer patients dying in the hospitalSharon Tamir, Daniel Kurnik, Myriam Weyl Ben-Arush, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
European Journal of Preventive Cardiology|February 6, 2013
Estimated glomerular filtration rate in a population with normal to mildly reduced renal function as predictor of cardiovascular diseaseGilad Yahalom, Shaye Kivity, Shlomo Segev, et al.
The Annals of Pharmacotherapy|October 21, 2003
Multivitamin supplements may affect warfarin anticoagulation in susceptible patientsDaniel Kurnik, Aharon Lubetsky, Ronen Loebstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Potential dosing errors using portable prothrombin time monitoring devicesRonen Loebstein, Daniel Kurnik, Aharon Lubetsky, et al.
Clinical Pharmacology and Therapeutics|September 11, 2003
Increased warfarin doses and decreased international normalized ratio response after nationwide generic switchingHillel Halkin, Jonathan Shapiro, Daniel Kurnik, et al.
Thrombosis and Haemostasis|November 16, 2004
Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trialDaniel Kurnik, Ronen Loebstein, Hadas Rabinovitz, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|April 18, 2026
Does mifamurtide affect the elimination of high-dose methotrexate in children with osteosarcoma?Maayan Antebi, Laila Nassar, Daniel Kurnik, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activityDaniel Kurnik, Alastair J J Wood, Grant R Wilkinson
British Journal of Clinical Pharmacology|July 27, 2010
Warfarin and vitamin K intake in the era of pharmacogeneticsYael Lurie, Ronen Loebstein, Daniel Kurnik, et al.
The Israel Medical Association Journal : IMAJ|July 12, 2021
Polypharmacy among pediatric cancer patients dying in the hospitalSharon Tamir, Daniel Kurnik, Myriam Weyl Ben-Arush, et al.
Pharmacogenomics|December 5, 2009
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisalDaniel Kurnik, Ronen Loebstein, Hillel Halkin, et al.
European Journal of Preventive Cardiology|February 6, 2013
Estimated glomerular filtration rate in a population with normal to mildly reduced renal function as predictor of cardiovascular diseaseGilad Yahalom, Shaye Kivity, Shlomo Segev, et al.
The Annals of Pharmacotherapy|October 21, 2003
Multivitamin supplements may affect warfarin anticoagulation in susceptible patientsDaniel Kurnik, Aharon Lubetsky, Ronen Loebstein, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
Potential dosing errors using portable prothrombin time monitoring devicesRonen Loebstein, Daniel Kurnik, Aharon Lubetsky, et al.
Clinical Pharmacology and Therapeutics|September 11, 2003
Increased warfarin doses and decreased international normalized ratio response after nationwide generic switchingHillel Halkin, Jonathan Shapiro, Daniel Kurnik, et al.
Thrombosis and Haemostasis|November 16, 2004
Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trialDaniel Kurnik, Ronen Loebstein, Hadas Rabinovitz, et al.
Pageof 9